Mathilde M. Almekinders

426 total citations
7 papers, 198 citations indexed

About

Mathilde M. Almekinders is a scholar working on Oncology, Cancer Research and Rheumatology. According to data from OpenAlex, Mathilde M. Almekinders has authored 7 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Cancer Research and 2 papers in Rheumatology. Recurrent topics in Mathilde M. Almekinders's work include Breast Cancer Treatment Studies (3 papers), Systemic Lupus Erythematosus Research (2 papers) and Breast Lesions and Carcinomas (1 paper). Mathilde M. Almekinders is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), Systemic Lupus Erythematosus Research (2 papers) and Breast Lesions and Carcinomas (1 paper). Mathilde M. Almekinders collaborates with scholars based in Netherlands, Belgium and United Kingdom. Mathilde M. Almekinders's co-authors include Emilie C. Rijnink, Ingeborg M. Bajema, Y K Onno Teng, Karlien Cransberg, Suzanne Wilhelmus, Jan A. Bruijn, Ron Wolterbeek, Jelle Wesseling, Esther H. Lips and Lindy L. Visser and has published in prestigious journals such as The Journal of Immunology, Clinical Cancer Research and The American Journal of Surgical Pathology.

In The Last Decade

Mathilde M. Almekinders

7 papers receiving 194 citations

Peers

Countries citing papers authored by Mathilde M. Almekinders

Since Specialization

Citations

This map shows the geographic impact of Mathilde M. Almekinders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde M. Almekinders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde M. Almekinders more than expected).

Fields of papers citing papers by Mathilde M. Almekinders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde M. Almekinders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde M. Almekinders. The network helps show where Mathilde M. Almekinders may publish in the future.

Co-authorship network of co-authors of Mathilde M. Almekinders

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilde M. Almekinders. A scholar is included among the top collaborators of Mathilde M. Almekinders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilde M. Almekinders. Mathilde M. Almekinders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1 – NDRG1 deregulation 2023 ·Molecular Oncology ·Isabel Mayayo‐Peralta, (unknown), Stefan Preković, Karianne Schuurman, (unknown), Mathilde M. Almekinders, Joyce Sanders, Cathy B. Moelans, (unknown), Jelle Wesseling, P. J. van Diest, Rui Henrique, Cármen Jerónimo, Maarten Altelaar, Wilbert Zwart	5
2	Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ 2021 ·npj Breast Cancer ·Mathilde M. Almekinders, Michael Schaapveld, Bram Thijssen, Lindy L. Visser, Tycho Bismeijer, Joyce Sanders, Edoardo Isnaldi, Ingrid Hofland, Marjolijn Mertz, Lodewyk F.A. Wessels, Annegien Broeks, Erik Hooijberg, Wilbert Zwart, Esther H. Lips, Christine Desmedt, Jelle Wesseling	15
3	Increased microchimerism in peripheral blood of women with systemic lupus erythematosus: relation with pregnancy 2021 ·Clinical and Experimental Rheumatology ·(unknown), Emilie C. Rijnink, Malu Zandbergen, (unknown), Mathilde M. Almekinders, Jo H. M. Berden, Marc Bijl, E. Christiaan Hagen, (unknown), Gerda M. Steup‐Beekman, Ron Wolterbeek, Kitty W.M. Bloemenkamp, Hans J. Baelde, Jan A. Bruijn, Ingeborg M. Bajema, Suzanne Wilhelmus	2
4	Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS 2019 ·The American Journal of Surgical Pathology ·Lindy L. Visser, Lotte E. Elshof, Koen Van de Vijver, Emma J. Groen, Mathilde M. Almekinders, Joyce Sanders, Carolien Bierman, Dennis Peters, Ingrid Hofland, Annegien Broeks, Flora E. van Leeuwen, Emiel J. Rutgers, Marjanka K. Schmidt, Michael Schaapveld, Esther H. Lips, Jelle Wesseling	13
5	Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ —A Nested Case–Control Study 2018 ·Clinical Cancer Research ·Lindy L. Visser, Lotte E. Elshof, Michael Schaapveld, Koen Van de Vijver, Emma J. Groen, Mathilde M. Almekinders, Carolien Bierman, Flora E. van Leeuwen, Emiel J. Rutgers, Marjanka K. Schmidt, Esther H. Lips, Jelle Wesseling	31
6	Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis 2017 ·Clinical Journal of the American Society of Nephrology ·Emilie C. Rijnink, Y K Onno Teng, Suzanne Wilhelmus, Mathilde M. Almekinders, Ron Wolterbeek, Karlien Cransberg, Jan A. Bruijn, Ingeborg M. Bajema	108
7	Steric Hindrance and Fast Dissociation Explain the Lack of Immunogenicity of the Minor Histocompatibility HA-1Arg Null Allele 2009 ·The Journal of Immunology ·Eric Spierings, Stéphanie Gras, Jean‐Baptiste Reiser, (unknown), Mathilde M. Almekinders, Michel G.D. Kester, Anne Chouquet, (unknown), Jan W. Drijfhout, Ferry Ossendorp, Dominique Housset, Els Goulmy	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact